Does DACARBAZINE Cause Malignant neoplasm progression? 137 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 137 reports of Malignant neoplasm progression have been filed in association with DACARBAZINE (Dacarbazine). This represents 2.7% of all adverse event reports for DACARBAZINE.
137
Reports of Malignant neoplasm progression with DACARBAZINE
2.7%
of all DACARBAZINE reports
53
Deaths
40
Hospitalizations
How Dangerous Is Malignant neoplasm progression From DACARBAZINE?
Of the 137 reports, 53 (38.7%) resulted in death, 40 (29.2%) required hospitalization, and 9 (6.6%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DACARBAZINE. However, 137 reports have been filed with the FAERS database.
What Other Side Effects Does DACARBAZINE Cause?
Febrile neutropenia (501)
Off label use (471)
Neutropenia (400)
Drug ineffective (261)
Pyrexia (245)
Neuropathy peripheral (239)
Product use in unapproved indication (219)
Disease progression (204)
Nausea (203)
Anaemia (186)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which DACARBAZINE Alternatives Have Lower Malignant neoplasm progression Risk?
DACARBAZINE vs DACLATASVIR
DACARBAZINE vs DACLIZUMAB
DACARBAZINE vs DACOMITINIB
DACARBAZINE vs DACTINOMYCIN
DACARBAZINE vs DALBAVANCIN